Research Fix-Corp Int'l (BB:FIXC). Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Research Fix-Corp Int'l (BB:FIXC).

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Mr. Stress who wrote (771)	2/11/1998 10:56:00 AM
From: Jim B	of 1845

APPI... like I said... check this one out... Wednesday February 11, 10:00 am Eastern Time Company Press Release Advanced Plant Pharmaceuticals Announces Licensing Opportunity NEW YORK--(BUSINESS WIRE)--Feb. 11, 1998--Advanced Plant Pharmaceuticals Inc. (OTC Bulletin Board: APPI - news) announced today that they have begun negotiations with several large companies in the health-related market to license APPI's breakthrough technology. APPI intends to create a new category market in the pharmaceutical industry -- The ''Whole Plant Pharmaceutical.'' APPI is the first company in the history of the United States to receive a commercial IND on a whole plant pharmaceutical. APPI has identified two markets in which it intends to focus on licensing its technologies. 1) The Ethical Pharmaceutical Drug Market 2) The Nutritional Market which, according to independent market research, was valued at over nine billion dollars for 1996 APPI's whole plant pharmaceutical technology are trade secret and patent pending processes by which to turn a whole plant into your best standardized pharmaceutical grade product. APPI is a company that develops innovative plant formulations and technology for clinical application. APPI has met FDA nutritional specifications for the marketing of its LoChol in the United States, and has received the first IND from the FDA for a whole plant pharmaceutical which has potential as an immunomodulator. The initial studies are focusing on patients infected with HIV, the virus that causes AIDS. ------------------------------------------------------------------------ Contact: Advanced Plant Pharmaceuticals Inc. Sam Berkowitz 212/532-8114 Investor Package Martin Clare ------------------------------------------------------------------------ More Quotes and News:Advanced Plant Pharmaceuticals Inc (OTC BB:APPI - news)Related News Categories: medical/pharmaceutical any comments?? jim

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next